Author: et

CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN, June 22, 2026 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product

More

Shangri-La Group Debuts ‘Dragonbeat’ with Resounding Success, Cross-Industry Collaborations with Local Creators in Art, Fashion, Gastronomy and Music

HONG KONG, Jun 20, 2026 – (ACN Newswire via SeaPRwire.com) – Shangri-La Group (“Shangri-La” or the “Group”), title sponsor of the Shangri-La Stanley International Dragon Boat Championships, successfully presented its inaugural Dragon Boat Festival programme, Dragonbeat, yesterday at Stanley Main Beach.

More